Lupin gets nod from USFDA for Tenofovir Alafenamide Tablets

Lupin gets nod from USFDA for Tenofovir Alafenamide Tablets

by admin- Friday, March 31st, 2023 06:17:53 PM

 

Global pharma fundamental Lupin announced that it has obtained approval from america Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Tenofovir Alafenamide Tablets, 25 mg, a generic equal of Vemlidy Tablets, 25 mg, of Gilead Sciences, Inc. This product might be manufactured at Lupin’s Nagpur facility in India.

Tenofovir Alafenamide Tablets, 25 mg, had anticipated annual income of USD 531 million within the US.

News Updates